KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Non-cash Items (2012 - 2025)

Stereotaxis (STXS) reported Non-cash Items of $1.0 million for Q4 2025, up 100.0% year-over-year from $500000.0 in Q4 2024, and up 100.0% on a QoQ basis from $500000.0 in Q4 2024.

Stereotaxis (STXS) has 14 years of Non-cash Items data on file, last reported at $1.0 million in Q4 2025.

  • Quarterly Non-cash Items rose 100.0% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 100.0% YoY) and the FY2025 annual result came in at $1.0 million, up 100.0% from the prior year.
  • Non-cash Items advanced to $1.0 million in Q4 2025 per STXS's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $6.6 million in Q4 2021 and bottomed at $300000.0 in Q4 2023.
  • The 5-year median for Non-cash Items is $500000.0 (2022), against an average of $1.8 million.
  • The widest annual swing landed in 2022, when Non-cash Items sank 92.42%; it then surged 100.0% in 2025.
  • Tracing STXS's Non-cash Items over 5 years: stood at $6.6 million in 2021, then slumped by 92.42% to $500000.0 in 2022, then slumped by 40.0% to $300000.0 in 2023, then soared by 66.67% to $500000.0 in 2024, then surged by 100.0% to $1.0 million in 2025.
  • Per Business Quant, the three latest STXS Non-cash Items figures stand at $1.0 million (Q4 2025), $500000.0 (Q4 2024), and $300000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.00 Mn
Dec 31, 2025 1.00 Mn
Dec 31, 2024 500,000.00
Dec 31, 2024 500,000.00
Dec 31, 2023 300,000.00
Dec 31, 2023 300,000.00
Dec 31, 2022 500,000.00
Dec 31, 2022 500,000.00
Dec 31, 2021 6.60 Mn
Dec 31, 2021 6.60 Mn
Dec 31, 2020 5.90 Mn
Dec 31, 2020 5.90 Mn
Dec 31, 2019 6.60 Mn
Dec 31, 2019 6.60 Mn
Dec 31, 2018 300,000.00
Dec 31, 2018 300,000.00
Dec 31, 2017 1,800.00
Dec 31, 2017 1,800.00
Dec 31, 2016 12,250.00
Dec 31, 2016 12,250.00
Dec 31, 2015 235,572.00
Dec 31, 2015 235,572.00
Dec 31, 2014 148,370.00
Dec 31, 2014 148,370.00
Dec 31, 2013 100,000.00
Dec 31, 2013 100,000.00
Dec 31, 2012 5,298.00
Dec 31, 2012 5,298.00